Proliferative suppression and class I insufficiency on peripheral blood cells from hepatitis C patients overcome by exogenous cytokines or high-dose mitogen

Clinical Immunology

Volumn 103, Issue 3 I, 2002, Pages 317-323

  Kimball, Pam ^a   Verbeke, Scott ^a   Shiffman, Mitchell ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Hepatitis C; HLA; Immunomodulation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 2; MITOGENIC AGENT; PHYTOHEMAGGLUTININ;

ARTICLE; BIOCHEMISTRY; CHRONICITY; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS C; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE;

EID: 0036087685     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5217     Document Type: Article

References (31)

1. Pathogenesis, natural history, treatment and prevention of hepatitis C
2. Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers
3. The mechanisms of chronicity in Hepatitis C virus infection
4. Evasion of host immune surveillance by hepatitis C virus: Potential roles in viral persistence
5. + T lymphocytes after infection with hepatitis C virus
6. Intrahepatic mRNA expression of interferon inducible antiviral genes in liver disease: dsRNA dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C
7. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR independent manner
8. Intrahepatic hepatitis C virus specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
9. Immunological responses in patients who have spontaneously eradicated hepatitis C virus infection
10. Peripheral blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
11. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides binding to HLA A2.1 molecules
12. Identification of immunodominant hepatitis C virus specific cytotoxic T cell epitopes by stimulation with endogenously synthesized HCV antigens
13. + T cell expansion in patients with acute hepatitis C
14. MHC dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
15. Regulation of major histocompatibility complex Class I gene expression in thyroid cells
16. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex Class I processing and presentation in vitro
17. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
18. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-α therapy
19. Production of cytokines in patients infected by hepatitis C virus
20. Quantitative analysis of specific Th1/Th2 helper cell response and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C
21. Different levels oft cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus specific human C (+) T cell clones
22. Quantitative analysis of hepatitis C virus in peripheral blood and liver: Replication detected only in liver
23. Two episodes of calcium uptake required for T cell activation
24. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells
25. Soluble HLA Class I antigens in chronic hepatitis C: A disease associated manifestation or molecules modulating immunoresponsiveness
26. Cooperation of liver cells in health and disease
27. Hepatocellular expression of HLA-A, B, C molecules predicts primary response to interferon in patients with chronic hepatitis C
28. Class I and class II major histocompatibility complex antigen expression on human hepatocytes and hepatoma cells: An approach with high sensitivity and specificity
29. HLA Class I expression on peripheral blood lymphocytes and hepatocytes after liver transplantation
30. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C
31. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection